SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

15.88p
   
  • Change Today:
    -0.38p
  • 52 Week High: 19.50p
  • 52 Week Low: 7.25p
  • Currency: UK Pounds
  • Shares Issued: 228.44m
  • Volume: 615,738
  • Market Cap: £36.26m
  • Beta: 1.22

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2271.3% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 274.6 n/a
Pr/Book 18.2  
Latest F'cast
Revenue 76.6% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SBTX Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 n/a (1.36) (0.94)p n/a n/a n/a n/a 0.0%
30-Jun-20 n/a (1.62) (1.17)p n/a n/a n/a n/a 0.0%
30-Jun-21 n/a (1.50) (0.01)p n/a n/a n/a n/a 0.0%
30-Jun-22 0.07 (2.99) (1.78)p n/a n/a n/a n/a 0.0%
30-Jun-23 0.13 (3.01) (1.72)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SBTX Company Announcements

Finalisation of commercial agreement with Croda 19-Nov-2024 07:00 RNS
Holding(s) in Company 25-Oct-2024 16:29 RNS
Integration update and share price movement 23-Oct-2024 14:40 RNS

SBTX ShareCast News

SkinBioTherapeutics shares jump on acquisition o... 11-Oct-2024 ShareCast
SkinBioTherapeutics reports positive results fro... 19-Sep-2024 ShareCast
SkinBioTherapeutics secures £1.56m from new inve... 02-Aug-2024 ShareCast

Latest SBTX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

SBTX Market Data

Currency UK Pounds
Share Price 15.88p
Change Today -0.38p
% Change -2.31 %
52 Week High 19.50p
52 Week Low 7.25p
Volume 615,738
Shares Issued 228.44m
Market Cap £36.26m
Beta 1.22

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
72.99% below the market average72.99% below the market average72.99% below the market average72.99% below the market average72.99% below the market average
96% below the sector average96% below the sector average96% below the sector average96% below the sector average96% below the sector average
Price Trend
1.45% above the market average1.45% above the market average1.45% above the market average1.45% above the market average1.45% above the market average
51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average
Income Not Available
Growth
21.88% above the market average21.88% above the market average21.88% above the market average21.88% above the market average21.88% above the market average
11.76% above the sector average11.76% above the sector average11.76% above the sector average11.76% above the sector average11.76% above the sector average

SBTX Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
15:51 7,500 @ 15.95p
14:41 100,000 @ 15.75p
14:39 100,000 @ 15.75p
15:10 6 @ 15.50p
15:10 187 @ 16.00p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page